Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Wenyang Jiedu Prescription for Postoperative Gastric Cancer
NCT05229809Phase 4Unknown
- Start
- Mar 2022
- Primary completion
- Jul 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Yiqi Wenyang Jiedu prescription in gastric cancer (GC). Status: unknown.
02
Drugs
Yiqi Wenyang Jiedu prescription
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05229809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229809.